News

InnoCore Pharmaceuticals has been awarded a grant by the Bill & Melinda Gates Foundation to develop a long-acting injectable contraceptive implant

Groningen, The Netherlands, September 11, 2020, InnoCore Pharmaceuticals, a Dutch pharmaceutical drug delivery and development...

Read more
InnoCore Pharmaceuticals to join Bill & Melinda Gates Foundation supported consortium to develop long-acting microneedle contraceptive

Groningen, The Netherlands, January 15th, 2019, InnoCore Pharmaceuticals, a Dutch pharmaceutical drug delivery and development...

Read more
Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology

  Groningen, The Netherlands, July 26, 2018 – InnoCore Pharmaceuticals and Merck KGaA (operating as MilliporeSigma...

Read more
InnoCore renewed the GMP certificate

Groningen, February 6th, 2018: InnoCore Pharmaceuticals renewed the GMP certificate including laboratory authorization...

Read more
InnoCore has been awarded with the "Groningen Ondernemingsprijs 2017"

Groningen, 30th November 2017. With the development of long-term active medicines, InnoCore Pharmaceuticals has won the Groningen...

Read more
Exclusive License Agreement with Allergan

Groningen, October 22, 2013: InnoCore Pharmaceuticals Enters into Exclusive License Agreement with Allergan Related to...

Read more

We use cookies for analyzing visitors behavior.